Cycle-length evidence
Vasopressin cycle length: what human studies ran
FDA-approvedAHuman trial evidence
Short answer: Vasopressin has no "cycle". As an approved drug it is used as its label and a prescriber direct.
Treatment and follow-up in human studies
No human study durations are recorded.
What has not been tested
- On-and-off schedules or breaks between courses.
- Repeated courses and long-term exposure beyond the periods listed.
- Vasopressin combined with other compounds, unless a study above says so.
Frequently asked questions
Is there an established Vasopressin cycle length?
No cycle is defined. Vasopressin is an approved drug whose label describes treatment under a prescriber's care; the label, not a cycle, governs duration.
What is the longest human study of Vasopressin?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
References
- VASOSTRICT (vasopressin) injection, prescribing information (DailyMed SPL version 49, published May 20, 2026) FDA label (DailyMed). 2026
- Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med. 2008
- Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial JAMA. 2016
- Tractatenblad 2026 Nr. 25: Anti-doping convention (ETS No. 135), amendment to the appendix - The 2026 Prohibited List, World Anti-Doping Code (English text; entry into force 1 January 2026) Tractatenblad van het Koninkrijk der Nederlanden (official government publication). 2026
- PubChem compound record for argipressin (arginine vasopressin; CID 644077) PubChem. 2026